Strengthening the Corporate Structure Through Digital Transformation and Other Initiatives
First written in FY2022. 6 of 10 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2025: 7 of 30 companies on the "Worse" side.
16 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「We will promote organisational culture change, strengthen the human resources management structure and enable diverse personnel to thrive through the efficient use of human resources and infrastructure. We will also work to develop the infrastructure supporting the management foundation.」
The company continues the direction set out in the 25-27 Medium-Term Management Plan for strengthening the management foundation, utilising human resources and developing infrastructure. - FY2026-H1RestatedAnnual report
「In fiscal 2025, we formulated the 25-27 Medium-Term Management Plan, positioned as "3 years of accelerating the growth strategy" toward achieving our desired position. Under this plan, we are focusing on the following key themes: "strengthening the earnings power of core businesses," "continued investment in growth businesses," and "strengthening the management foundation supporting growth."」
The 25-27 Medium-Term Management Plan continues to identify strengthening the management foundation supporting growth as a priority theme. - FY2025AdvancedAnnual report
「During the Medium-Term Management Plan, we made efforts to create innovation and improve productivity by making maximum use of infrastructure and other resources that had been put into operation.」
The company states that the use of infrastructure and other resources put into operation during the 22-24 Medium-Term Management Plan will carry over into the next plan, and that it established a new Medical Device Business Development Department to strengthen the biomaterials business. - FY2024AdvancedAnnual report
「With respect to strengthening the corporate infrastructure for creating innovation and improving productivity, we established and began operating the necessary systems, including a new human resources and compensation system and a new customer management system.」
The company reports specific progress in strengthening its corporate infrastructure through the establishment and launch of a new human resources and compensation system and a new customer management system. - FY2024-Q3RestatedAnnual report
「To this end, we have made focused efforts to address the challenges of “maximizing revenue in priority areas centered on new drugs,” “investing in business activities that contribute to future competitiveness,” and “strengthening our corporate structure to drive innovation and improve productivity.”」
The company continues to strengthen its corporate infrastructure for creating innovation and improving productivity as one of its priority challenges, but no new specific measures or achievement milestones are disclosed. - FY2023AdvancedAnnual report
「To strengthen our corporate infrastructure, we advanced business reforms using digital technologies. We also reviewed how compensation reflects roles and contributions, established a new human resources and compensation system incorporating work styles that enable diverse personnel to thrive, and began operating the system.」
The company reports specific progress in strengthening its corporate infrastructure through business reforms using DX and the establishment and launch of a new human resources and compensation system. - FY2023-Q3RestatedAnnual report
「To this end, we have made focused efforts to address the challenges of “maximizing revenue in priority areas centered on new drugs,” “investing in business activities that contribute to future competitiveness,” and “strengthening our corporate structure to drive innovation and improve productivity.”」
The company continues to strengthen its corporate infrastructure for creating innovation and improving productivity as one of its priority challenges. - FY2023-Q2RestatedAnnual report
「To this end, we have made focused efforts to address the challenges of “maximizing revenue in priority areas centered on new drugs,” “investing in business activities that contribute to future competitiveness,” and “strengthening our corporate structure to drive innovation and improve productivity.”」
The company continues to strengthen its corporate infrastructure for creating innovation and improving productivity as one of its priority challenges. - FY2023-Q1RestatedAnnual report
「To this end, we have made focused efforts to address the challenges of “maximizing revenue in priority areas centered on new drugs,” “investing in business activities that contribute to future competitiveness,” and “strengthening our corporate structure to drive innovation and improve productivity.”」
The company continues to strengthen its corporate infrastructure for creating innovation and improving productivity as one of its priority challenges. - FY2022First statedAnnual report
「During the 22-24 Medium-Term Management Plan, our group will focus on the following challenges under the themes of creating innovation and improving productivity. We will harmonise and coordinate 4 approaches: optimising business processes and business quality levels, promoting digital transformation, reforming systems and promoting facilities management, thereby achieving efficient organisational management and enhancing corporate value.」
The 22-24 Medium-Term Management Plan explicitly identifies, as a new standalone initiative, productivity improvement measures combining business processes and quality, DX, system reform and facilities management.